Share
About SHINE Medical Technologies
SHINE is a nuclear technology company committed to improving the lives of patients around the world. The company is focused initially on the commercialization of medical isotopes, including molybdenum-99, a diagnostic isotope used to diagnose heart disease, cancer and other diseases, and lutetium-177, a therapeutic isotope that holds the promise of significantly improving the outcomes for some cancer patients. SHINE has created isotope production processes that will deliver products to benefit physicians and patients and help solve critical supply problems in the United States and markets in Europe and around the world. SHINE has a long-term strategy to solve some of humanity’s biggest problems and advance our vision for progressively broad and impactful uses of nuclear technology. For more information, please visit our website at www.shinemed.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20201123006188/en/
Contacts
MALLORY PROUTY CORPORATE COMMUNICATIONS PROJECT MANAGER, MBA mallory.prouty@shinemed.com P: 608-530-5606 | M: 630-945-2379
ROD HISE DIRECTOR, MARKETING & CORPORATE COMMUNICATIONS rod.hise@shinemed.com P 608-530-5659 | M 608-770-7850